Pathstone Family Office’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $4.67M | Buy |
|
|||||
|
2023
Q2 | $3.26M | Sell |
|
|||||
|
2023
Q1 | $3.51M | Sell |
|
|||||
|
2022
Q4 | $6.54M | Sell |
|
|||||
|
2022
Q3 | $5.86M | Buy |
|
|||||
|
2022
Q2 | $2.2M | Buy |
|
|||||
|
2022
Q1 | $1.81M | Buy |
|
|||||
|
2021
Q4 | $1.65M | Buy |
|
|||||
|
2021
Q3 | $1.1M | Buy |
|
|||||
|
2021
Q2 | $372K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $20K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $164K | Sell |
|
|||||
|
2020
Q1 | $300K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $18K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $11K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $15K | Hold |
|
|||||
|
2017
Q1 | $12K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $21K | Hold |
|
|||||
|
2016
Q2 | $27K | Buy |
|